Pharma Mar | PHM - Stammkapital

Aktienkurs
102.80
Täglich Wechseln
-0.50 -0.48%
Monatlich
14.73%
Jährlich
39.30%
Q2 Prognose
93.55




Stammkapital Veränderung Datum
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Almirall EUR 214.79M 0 2025-12
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 260.32M 333K 2025-12
Pharma Mar EUR 17.36M 0 2026-03
Revvity USD 111.8M 1.57M 2026-03
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12